UBS Group’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-12,442
| Closed | -$184K | – | 9127 |
|
|
2024
Q1 | $184K | Sell |
12,442
-775
| -6% | -$11.4K | ﹤0.01% | 4767 |
|
|
2023
Q4 | $177K | Buy |
13,217
+7,369
| +126% | +$98.8K | ﹤0.01% | 4666 |
|
|
2023
Q3 | $72.1K | Sell |
5,848
-711
| -11% | -$8.77K | ﹤0.01% | 4939 |
|
|
2023
Q2 | $80.7K | Buy |
6,559
+3,431
| +110% | +$42.2K | ﹤0.01% | 5120 |
|
|
2023
Q1 | $38.4K | Buy |
3,128
+2,353
| +304% | +$28.9K | ﹤0.01% | 5543 |
|
|
2022
Q4 | $8.88K | Sell |
775
-4,421
| -85% | -$50.7K | ﹤0.01% | 7523 |
|
|
2022
Q3 | $19K | Buy |
5,196
+3,952
| +318% | +$14.5K | ﹤0.01% | 6407 |
|
|
2022
Q2 | $8K | Sell |
1,244
-1,059
| -46% | -$6.81K | ﹤0.01% | 7391 |
|
|
2022
Q1 | $15K | Buy |
2,303
+2,106
| +1,069% | +$13.7K | ﹤0.01% | 6861 |
|
|
2021
Q4 | $1K | Hold |
197
| – | – | ﹤0.01% | 9066 |
|
|
2021
Q3 | $1K | Sell |
197
-302
| -61% | -$1.53K | ﹤0.01% | 8289 |
|
|
2021
Q2 | $3K | Sell |
499
-1,194
| -71% | -$7.18K | ﹤0.01% | 7801 |
|
|
2021
Q1 | $10K | Buy |
1,693
+1,496
| +759% | +$8.84K | ﹤0.01% | 6951 |
|
|
2020
Q4 | $1K | Hold |
197
| – | – | ﹤0.01% | 7303 |
|
|
2020
Q3 | $1K | Hold |
197
| – | – | ﹤0.01% | 7033 |
|
|
2020
Q2 | $1K | Sell |
197
-2,353
| -92% | -$11.9K | ﹤0.01% | 7020 |
|
|
2020
Q1 | $5K | Buy |
2,550
+2,353
| +1,194% | +$4.61K | ﹤0.01% | 6435 |
|
|
2019
Q4 | $1K | Sell |
197
-2,558
| -93% | -$13K | ﹤0.01% | 6978 |
|
|
2019
Q3 | $13K | Buy |
2,755
+1,996
| +263% | +$9.42K | ﹤0.01% | 6069 |
|
|
2019
Q2 | $4K | Sell |
759
-1,922
| -72% | -$10.1K | ﹤0.01% | 6626 |
|
|
2019
Q1 | $14K | Sell |
2,681
-2,334
| -47% | -$12.2K | ﹤0.01% | 5788 |
|
|
2018
Q4 | $15K | Buy |
5,015
+2,207
| +79% | +$6.6K | ﹤0.01% | 6093 |
|
|
2018
Q3 | $12K | Buy |
2,808
+157
| +6% | +$671 | ﹤0.01% | 6178 |
|
|
2018
Q2 | $11K | Buy |
2,651
+1,994
| +304% | +$8.27K | ﹤0.01% | 6191 |
|
|
2018
Q1 | $4K | Sell |
657
-7,957
| -92% | -$48.4K | ﹤0.01% | 6489 |
|
|
2017
Q4 | $70K | Sell |
8,614
-605
| -7% | -$4.92K | ﹤0.01% | 4659 |
|
|
2017
Q3 | $105K | Buy |
9,219
+2,451
| +36% | +$27.9K | ﹤0.01% | 4422 |
|
|
2017
Q2 | $66K | Sell |
6,768
-12,560
| -65% | -$122K | ﹤0.01% | 4564 |
|
|
2017
Q1 | $468K | Sell |
19,328
-10,045
| -34% | -$243K | ﹤0.01% | 3318 |
|
|
2016
Q4 | $943K | Buy |
29,373
+17,047
| +138% | +$547K | ﹤0.01% | 2847 |
|
|
2016
Q3 | $615K | Sell |
12,326
-12,282
| -50% | -$613K | ﹤0.01% | 3026 |
|
|
2016
Q2 | $1.04M | Buy |
24,608
+6,967
| +39% | +$296K | ﹤0.01% | 2668 |
|
|
2016
Q1 | $1.16M | Sell |
17,641
-25,695
| -59% | -$1.69M | ﹤0.01% | 2540 |
|
|
2015
Q4 | $2.69M | Buy |
43,336
+18,696
| +76% | +$1.16M | ﹤0.01% | 1973 |
|
|
2015
Q3 | $1.65M | Sell |
24,640
-4
| -0% | -$268 | ﹤0.01% | 2283 |
|
|
2015
Q2 | $2.4M | Sell |
24,644
-2,681
| -10% | -$261K | ﹤0.01% | 2170 |
|
|
2015
Q1 | $2.55M | Buy |
27,325
+6,037
| +28% | +$564K | ﹤0.01% | 2114 |
|
|
2014
Q4 | $1.89M | Buy |
+21,288
| New | +$1.89M | ﹤0.01% | 2285 |
|